1. Field of the Invention
The present invention relates generally to medical methods and apparatus. More particularly, the present invention relates to methods and devices for restricting spinal flexion in patients having back pain or other spinal conditions.
A major source of chronic low back pain is discogenic pain, also known as internal disc disruption. Patients suffering from discogenic pain tend to be young, otherwise healthy individuals who present with pain localized to the back. Discogenic pain usually occurs at the discs located at the L4-L5 or L5-S1 junctions of the spine (
This pain experienced by patients with discogenic low back pain can be thought of as flexion instability and is related to flexion instability that is manifested in other conditions. The most prevalent of these is spondylolisthesis, a spinal condition in which abnormal segmental translation is exacerbated by segmental flexion.
Current treatment alternatives for patients diagnosed with chronic discogenic pain are quite limited. Many patients follow a conservative treatment path, such as physical therapy, massage, anti-inflammatory and analgesic medications, muscle relaxants, and epidural steroid injections, but typically continue to suffer with a significant degree of pain. Other patients elect to undergo spinal fusion surgery, which commonly requires discectomy (removal of the disk) together with fusion of adjacent vertebrae. Fusion is not usually recommended for discogenic pain because it is irreversible, costly, associated with high morbidity, and of questionable effectiveness. Despite its drawbacks, however, spinal fusion for discogenic pain remains common due to the lack of viable alternatives.
Recently, a less invasive and potentially more effective treatment for discogenic pain has been proposed. A spinal implant has been designed which inhibits spinal flexion while allowing substantially unrestricted spinal extension. The implant is placed over one or more adjacent pairs of spinal processes and provides an elastic restraint to the spreading apart of the spinal processes which occurs during flexion. Such devices and methods for their use are described in U.S. Patent Application 2005/02161017A1, published on Sep. 29, 2005, and having common inventors with the present application.
As illustrated in
Ideally, the compliance members 16 will remain horizontally aligned and spaced generally between the spinous processes SP4 and SP5, as shown generally in
For these reasons, it would be desirable to provide improved spinal implants and methods for their use in inhibiting flexion in patients suffering from discogenic pain. It would be particularly desirable if the improved devices would provide the desired elastic forces to the spinous processes without displacement or loss of symmetry of the device over time. At least some of these objectives will be met by the inventions described hereinbelow.
2. Description of the Background Art
US 2005/0216017A1 has been described above. Other patents and published applications of interest include: U.S. Pat. Nos. 4,966,600; 5,011,494; 5,092,866; 5,116,340; 5,282,863; 5,395,374; 5,415,658; 5,415,661; 5,449,361; 5,456,722; 5,462,542; 5,496,318; 5,540,698; 5,609,634; 5,645,599; 5,725,582; 5,902,305; Re. 36,221; 5,928,232; 5,935,133; 5,964,769; 5,989,256; 6,053,921; 6,312,431; 6,364,883; 6,378,289; 6,391,030; 6,468,309; 6,436,099; 6,451,019; 6,582,433; 6,605,091; 6,626,944; 6,629,975; 6,652,527; 6,652,585; 6,656,185; 6,669,729; 6,682,533; 6,689,140; 6,712,819; 6,689,168; 6,695,852; 6,716,245; 6,761,720; 6,835,205; Published U.S. Patent Application Nos. US 2002/0151978; US 2004/0024458; US 2004/0106995; US 2004/0116927; US 2004/0117017; US 2004/0127989; US 2004/0172132; US 2005/0033435; US 2005/0049708; US 2006/0069447; Published PCT Application Nos. WO 01/28442 A1; WO 02/03882 A2; WO 02/051326 A1; WO 02/071960 A1; WO 03/045262 A1; WO 2004/052246 A1; WO 2004/073532 A1; and Published Foreign Application Nos. EP 0322334 A1; and FR 2 681 525 A1.
The present invention provides spinal implants and methods for restricting spinal flexion for the treatment of discogenic pain and other spinal conditions, such as spondylolisthesis, where the physician desires to control spinal flexion. The spinal implants comprise a tether structure adapted to encircle at least two spinous processes, where at least a portion of the tether structure is adapted to elastically elongate to apply tension to the spinous processes as the spine undergoes flexion, i.e. as the spinous processes move apart as the patient leans forward. The tether structure may comprise any of the particular structures described in detail in U.S. patent application Ser. No. 11/076,469, filed on Mar. 9, 2005, and published as US 2005/0216017 A1, the full disclosure of which is incorporated herein by reference.
In particular, in the simplest embodiments, the tether structure may comprise a single, continuous loop of material wherein all or a portion of the loop is formed of a compliant material to provide the desired elasticity. More commonly, the tether structure will comprise one or more band segments joined by one or more compliance members, where the band(s) are typically non-distensible and the compliance member(s) provide for the desired elasticity. In some instances, the compliance members may comprise spring or other elements which provide an elastic tensioning force where the band member(s) are attached to opposite ends of the spring member. In other instances, the compliance members could include elastomeric or other compression elements, where the band member(s) are attached to opposed sides of the compressive elements so that the elasticity is provided by compression on the compression member.
In preferred embodiments, the tether structure will comprise a pair of band members joined by a pair of compliance members, where an upper band member will be placed over the superior surface of an upper spinous process and the lower band member will be placed over an inferior surface of the lower spinous process. The compliance members will be generally horizontally aligned across the region between the upper and lower spinous processes. A connecting mechanism may loin the pair of band members.
In a particular aspect of the present invention, the spinal implants will include at least one cross-member coupled to opposed portions of the tether structure, where the cross-member is positioned to lie between the spinous processes when the tether structure encircles the processes as described above. In specific embodiments, the cross-member will extend between the horizontally aligned compliance members, but in other embodiments a cross-member could be coupled to other portions or components of the tether structure, including the band or loop elements which are disposed over the spinous processes.
The cross-member(s) functions to stabilize the tether structure after the tether structure has been implanted over the spinous processes. In particular, the cross-member(s) will help maintain the symmetry of the device so that it does not circumferentially rotate or migrate over the spinous processes, which is a potential problem when the tether includes one or more compliance members. In addition, the cross-member(s) may optionally maintain the lateral spacing between the two sides of the device, such as between a pair of horizontally aligned compliance members. The cross-member(s) may further prevent or inhibit vibration or sinusoidal movement of the device which may result from dynamic and/or cyclic loading.
In addition to the stabilization functions, a cross-member may help in initial placement and positioning of the tether structure. For example, a tether structure including a pair of horizontally aligned compliance members may be introduced and assembled in situ, where the cross-member helps establish the initial horizontal alignment between the compliance members. Alternatively, when no compliance members are to be used, the cross-member could itself provide for connection points for attaching upper and lower band segments. Additionally, the cross-member(s) can create pivot points to allow rotation or pivoting of the band relative to the cross-member(s) as well as the other band segments.
The cross-member(s) may have a wide variety of particular configurations. The most common cross-member(s) will have generally rigid structures, e.g. in the form of a rod, bar, beam, or the like. In other instances, however, the cross-member(s) may be relatively flexible, in some cases being in the form of a wire, ribbon, string, spring, suture, or the like. In still other configurations, the cross-member(s) may be linearly compressible, but not extensible, in order to allow for a controlled degree of inward motion of the tether structure after it has been placed. In still other configurations, the cross-member(s) may be linearly non-compressible, but allow for a small degree of axial extension in order to prevent inward motion or intrusion of the tether structure into the region between the spinous processes.
There are also a variety of ways in which the cross-member(s) may be attached to the tether structure. Typically, the cross-member(s) will be attached to opposed compliance members (usually to housings of the compliance member subassemblies as shown in the '017 application previously incorporated by reference), where the attachment can be rigid, semi-rigid, pivotal, or the like. In a first exemplary embodiment, the cross-member is rigidly attached to a pair of compliance members in a generally H-shaped configuration. In other instances, the connections may be pivotal or non-rigid, as mentioned above. Still further, the cross-member can be completely flexible which would allow for a small degree of motion between the compliance members after implantation.
While most embodiments of the present invention will employ only a single cross-member, in other embodiments two or more cross-members may be used. For example, a pair of cross-members may be positioned between opposed portions of the tether structure, where an upper cross-member is located immediately below the inferior surface of the upper spinal process, while the lower cross-member is positioned immediately adjacent to a superior surface of the lower spinal process. Alternatively, such cross-member pairs may be positioned more closely to the compliance members, e.g. where they lie immediately above and below the compliance members. In still other embodiments, the cross-members may be slidably attached to the bands or other portions of the tether structure so that the cross-members may move in response to a force applied by the spinous processes or otherwise.
In all the embodiments of the present invention, it will be desirable that the cross-member(s) provide little or no resistance to extension, i.e. motion of the adjacent spinous processes toward one another. When the cross-member consists of a single rod, bar, structure, or other flexible element extending between exposed portions of the tether structure, the cross-member will usually have a very small vertical height (typically less than 6 mm, usually in the range from 1 mm to 3 mm), and it is unlikely that the cross-member would contact either spinous process even in an extreme degree of extension, so long as the cross-member is located at a position which is equally spaced apart from the two spinous processes. In other instances, however, the cross-member could have a larger cross-sectional profile which might contact either or both spinous processes as the spine undergoes extension. In such cases, it is desirable that the cross-member be collapsible or otherwise provide minimum force against either or both processes.
Usually, the cross-member will be implanted through the interspinous ligament which extends between the upper and lower spinous processes. In such instances, it is desirable that the cross-member itself have a relatively low profile to permit passage through the ligament with minimum trauma. Often, it will be desirable to have the cross-member detachable from at least one of the opposed tether structure components so that the cross-members or other portions of the tether structure do not need to be passed through the interspinous ligament.
In another aspect of the present invention, methods for stabilizing spinal flexion comprise positioning a continuous tether structure over a pair of adjacent spinous processes on adjacent vertebrae to elastically restrict flexion. The tether structure will be positioned and have mechanical properties which will elastically tension the processes when the processes are in flexion. In accordance with the principles of the present invention, opposed portions of the tether structure are mechanically coupled, usually through the interspinous ligament, in order to stabilize the structure, particularly to inhibit circumferential displacement of the tether structure over time.
In the exemplary embodiments, the opposed portions of the tether structure will comprise compliance members, and it will be the compliance members which are mechanically coupled to stabilize the structure in situ. Typically, the compliance members will be connected by at least one cross-member wherein said at least one cross-member is fixably or non-fixably attached to the compliance members. In some embodiments, one end of the cross-member may be fixably attached to one compliance member while the other member is non-fixably attached to the other compliance member. The cross-member itself may be rigid, semi-rigid, or non-rigid, and in all instances the cross-member will provide no significant inhibition of spinal extension. Preferably, the cross-member will pass through the interspinous ligament without significant damage or compromise to its integrity.
Optionally, one or more additional tether structures may be implanted around other pair(s) of spinous processes in the manner described above.
Referring now to
As shown in
A pair of cross-members 60 are illustrated in
While the above is a complete description of the preferred embodiments of the invention, various alternatives, modifications, and equivalents may be used. Therefore, the above description should not be taken as limiting the scope of the invention which is defined by the appended claims.
This application claims the benefit of prior provisional application 60/862,085, filed on Oct. 19, 2006, the full disclosure of which is incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
3648691 | Lumb et al. | Mar 1972 | A |
4246660 | Wevers | Jan 1981 | A |
4643178 | Nastari et al. | Feb 1987 | A |
4708132 | Silvestrini | Nov 1987 | A |
4743260 | Burton | May 1988 | A |
4772286 | Goble et al. | Sep 1988 | A |
4776851 | Bruchman et al. | Oct 1988 | A |
4794916 | Porterfield et al. | Jan 1989 | A |
4870957 | Goble et al. | Oct 1989 | A |
4955910 | Bolesky | Sep 1990 | A |
4966600 | Songer et al. | Oct 1990 | A |
5002574 | May et al. | Mar 1991 | A |
5011484 | Breard | Apr 1991 | A |
5092866 | Breard et al. | Mar 1992 | A |
5108433 | May et al. | Apr 1992 | A |
5116340 | Songer et al. | May 1992 | A |
5171280 | Baumgartner | Dec 1992 | A |
5180393 | Commarmond | Jan 1993 | A |
5282863 | Burton | Feb 1994 | A |
5354917 | Sanderson et al. | Oct 1994 | A |
5395374 | Miller et al. | Mar 1995 | A |
5415658 | Killpela et al. | May 1995 | A |
5415661 | Holmes | May 1995 | A |
5449361 | Preissman | Sep 1995 | A |
5456722 | McLeod et al. | Oct 1995 | A |
5458601 | Young, Jr. et al. | Oct 1995 | A |
5462542 | Alesi, Jr. | Oct 1995 | A |
5496318 | Howland et al. | Mar 1996 | A |
5540698 | Preissman | Jul 1996 | A |
5562737 | Graf | Oct 1996 | A |
5609634 | Voydeville | Mar 1997 | A |
5628756 | Barker, Jr. et al. | May 1997 | A |
5645084 | McKay | Jul 1997 | A |
5645599 | Samani | Jul 1997 | A |
5669917 | Sauer et al. | Sep 1997 | A |
5672175 | Martin | Sep 1997 | A |
5707379 | Fleenor et al. | Jan 1998 | A |
5725582 | Bevan et al. | Mar 1998 | A |
5902305 | Beger et al. | May 1999 | A |
RE36221 | Breard et al. | Jun 1999 | E |
5928232 | Howland et al. | Jul 1999 | A |
5933452 | Eun | Aug 1999 | A |
5935133 | Wagner et al. | Aug 1999 | A |
5964769 | Wagner et al. | Oct 1999 | A |
5989256 | Kuslich et al. | Nov 1999 | A |
6053921 | Wagner et al. | Apr 2000 | A |
6193721 | Michelson | Feb 2001 | B1 |
6224630 | Bao et al. | May 2001 | B1 |
6248106 | Ferree | Jun 2001 | B1 |
6283996 | Chervitz et al. | Sep 2001 | B1 |
6296643 | Hopf et al. | Oct 2001 | B1 |
6312431 | Asfora | Nov 2001 | B1 |
6322279 | Yamamoto et al. | Nov 2001 | B1 |
6364883 | Santilli | Apr 2002 | B1 |
6378289 | Trudeau et al. | Apr 2002 | B1 |
6391030 | Wagner et al. | May 2002 | B1 |
6395018 | Castaneda | May 2002 | B1 |
6436099 | Drewry et al. | Aug 2002 | B1 |
6451019 | Zucherman et al. | Sep 2002 | B1 |
6468309 | Lieberman | Oct 2002 | B1 |
6517578 | Hein | Feb 2003 | B2 |
6558389 | Clark et al. | May 2003 | B2 |
6582433 | Yun | Jun 2003 | B2 |
6605091 | Iwanski | Aug 2003 | B1 |
6616669 | Ogilvie et al. | Sep 2003 | B2 |
6626944 | Taylor | Sep 2003 | B1 |
6629975 | Kilpela et al. | Oct 2003 | B1 |
6652527 | Zucherman et al. | Nov 2003 | B2 |
6652585 | Lange | Nov 2003 | B2 |
6656185 | Gleason et al. | Dec 2003 | B2 |
6669729 | Chin | Dec 2003 | B2 |
6682533 | Dinsdale et al. | Jan 2004 | B1 |
6689140 | Cohen | Feb 2004 | B2 |
6689168 | Lieberman | Feb 2004 | B2 |
6695852 | Gleason | Feb 2004 | B2 |
6712819 | Zucherman et al. | Mar 2004 | B2 |
6716245 | Pasquet et al. | Apr 2004 | B2 |
6761720 | Senegas | Jul 2004 | B1 |
6828357 | Martin et al. | Dec 2004 | B1 |
6835205 | Atkinson et al. | Dec 2004 | B2 |
6899716 | Cragg et al. | May 2005 | B2 |
7029475 | Panjabi | Apr 2006 | B2 |
7163558 | Senegas et al. | Jan 2007 | B2 |
7201751 | Zucherman et al. | Apr 2007 | B2 |
7413576 | Sybert et al. | Aug 2008 | B2 |
7452351 | Miller et al. | Nov 2008 | B2 |
7458981 | Fielding et al. | Dec 2008 | B2 |
7520887 | Maxy et al. | Apr 2009 | B2 |
7524324 | Winslow | Apr 2009 | B2 |
7553320 | Molz, IV et al. | Jun 2009 | B2 |
7591837 | Goldsmith | Sep 2009 | B2 |
20020095154 | Atkinson et al. | Jul 2002 | A1 |
20020147449 | Yun | Oct 2002 | A1 |
20020151978 | Zacouto et al. | Oct 2002 | A1 |
20030088251 | Braun et al. | May 2003 | A1 |
20040024458 | Senegas et al. | Feb 2004 | A1 |
20040106995 | Le Couedic et al. | Jun 2004 | A1 |
20040116927 | Graf | Jun 2004 | A1 |
20040117017 | Pasquet et al. | Jun 2004 | A1 |
20040127989 | Dooris et al. | Jul 2004 | A1 |
20040143268 | Falahee | Jul 2004 | A1 |
20040167520 | Zucherman et al. | Aug 2004 | A1 |
20040172132 | Ginn | Sep 2004 | A1 |
20040215341 | Sybert et al. | Oct 2004 | A1 |
20040243239 | Taylor | Dec 2004 | A1 |
20050033435 | Belliard et al. | Feb 2005 | A1 |
20050049708 | Atkinson et al. | Mar 2005 | A1 |
20050123581 | Ringeisen et al. | Jun 2005 | A1 |
20050131405 | Molz, IV et al. | Jun 2005 | A1 |
20050154390 | Biedermann et al. | Jul 2005 | A1 |
20050192581 | Molz et al. | Sep 2005 | A1 |
20050216017 | Fielding et al. | Sep 2005 | A1 |
20050267470 | McBride | Dec 2005 | A1 |
20050267518 | Wright et al. | Dec 2005 | A1 |
20060036324 | Sachs et al. | Feb 2006 | A1 |
20060041259 | Paul et al. | Feb 2006 | A1 |
20060064166 | Zucherman et al. | Mar 2006 | A1 |
20060069447 | Disilvestro et al. | Mar 2006 | A1 |
20060084976 | Borgstrom et al. | Apr 2006 | A1 |
20060106381 | Ferree et al. | May 2006 | A1 |
20060106397 | Lins | May 2006 | A1 |
20060136060 | Taylor | Jun 2006 | A1 |
20060142760 | McDonnell | Jun 2006 | A1 |
20060149230 | Kwak et al. | Jul 2006 | A1 |
20060195102 | Malandain | Aug 2006 | A1 |
20060217726 | Maxy et al. | Sep 2006 | A1 |
20060240533 | Sengupta et al. | Oct 2006 | A1 |
20060241610 | Lim et al. | Oct 2006 | A1 |
20060271055 | Thramann | Nov 2006 | A1 |
20070010822 | Zalenski et al. | Jan 2007 | A1 |
20070073293 | Martz et al. | Mar 2007 | A1 |
20070083200 | Gittings et al. | Apr 2007 | A1 |
20070213829 | Le Couedic et al. | Sep 2007 | A1 |
20070233096 | Garcia-Bengochea | Oct 2007 | A1 |
20070270828 | Bruneau et al. | Nov 2007 | A1 |
20070299445 | Shadduck et al. | Dec 2007 | A1 |
20080009866 | Alamin et al. | Jan 2008 | A1 |
20080021466 | Shadduck et al. | Jan 2008 | A1 |
20080027435 | Zucherman et al. | Jan 2008 | A1 |
20080033552 | Lee et al. | Feb 2008 | A1 |
20080045949 | Hunt et al. | Feb 2008 | A1 |
20080051784 | Gollogly | Feb 2008 | A1 |
20080097431 | Vessa | Apr 2008 | A1 |
20080108993 | Bennett et al. | May 2008 | A1 |
20080114357 | Allard et al. | May 2008 | A1 |
20080125780 | Ferree | May 2008 | A1 |
20080177298 | Zucherman et al. | Jul 2008 | A1 |
20080183209 | Robinson et al. | Jul 2008 | A1 |
20080262549 | Bennett et al. | Oct 2008 | A1 |
20080281423 | Sheffer et al. | Nov 2008 | A1 |
20080312693 | Trautwein et al. | Dec 2008 | A1 |
20080319487 | Fielding et al. | Dec 2008 | A1 |
20090030457 | Janowski et al. | Jan 2009 | A1 |
20090082820 | Fielding et al. | Mar 2009 | A1 |
20090118766 | Park et al. | May 2009 | A1 |
20090198282 | Fielding et al. | Aug 2009 | A1 |
20090264929 | Alamin et al. | Oct 2009 | A1 |
20090264932 | Alamin et al. | Oct 2009 | A1 |
20090270918 | Attia et al. | Oct 2009 | A1 |
20100004701 | Malandain et al. | Jan 2010 | A1 |
20100023060 | Bennett et al. | Jan 2010 | A1 |
20100036424 | Fielding et al. | Feb 2010 | A1 |
20100234890 | Alamin et al. | Sep 2010 | A1 |
20100234894 | Alamin et al. | Sep 2010 | A1 |
20100249839 | Alamin et al. | Sep 2010 | A1 |
Number | Date | Country |
---|---|---|
0 322 334 | Jun 1989 | EP |
0 743 045 | Nov 1996 | EP |
1 994 901 | Nov 2008 | EP |
2 681 525 | Mar 1993 | FR |
2 714 591 | Jul 1995 | FR |
2 717 675 | Sep 1995 | FR |
2 851 154 | Aug 2004 | FR |
2874167 | Feb 2006 | FR |
2 884 136 | Oct 2006 | FR |
WO 0128442 | Apr 2001 | WO |
WO 0203882 | Jan 2002 | WO |
WO 02051326 | Jul 2002 | WO |
WO 02071960 | Sep 2002 | WO |
WO 03045262 | Jun 2003 | WO |
WO 2004052246 | Jun 2004 | WO |
WO 2004073532 | Sep 2004 | WO |
WO 2004073533 | Sep 2004 | WO |
WO 2005110258 | Nov 2005 | WO |
WO 2008051801 | May 2008 | WO |
WO 2008051802 | May 2008 | WO |
Number | Date | Country | |
---|---|---|---|
20080177264 A1 | Jul 2008 | US |
Number | Date | Country | |
---|---|---|---|
60862085 | Oct 2006 | US |